Mariam Amrani

Rabat, 10100, Morocco

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Prevalence of Polyomaviruses and Herpesviruses in Moroccan Breast Cancer.

Prevalence of Polyomaviruses and Herpesviruses in Moroccan Breast Cancer.

Journal: Pathogens (Basel, Switzerland)

Published: February 28, 2023

The Power of Biomarkers in Transforming Patients Care in Gynecologic Oncology.

The Power of Biomarkers in Transforming Patients Care in Gynecologic Oncology.

Journal: Current drug targets

Published: July 31, 2020

Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut.

Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut.

Journal: Expert review of clinical pharmacology

Published: April 21, 2020

Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer?

Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer?

Journal: Current drug targets

Published: November 05, 2019

Clinicopathological, Treatment and Event-Free Survival Characteristics in a Moroccan Population of Triple-Negative Breast Cancer.

Clinicopathological, Treatment and Event-Free Survival Characteristics in a Moroccan Population of Triple-Negative Breast Cancer.

Journal: Breast cancer : basic and clinical research

Published: May 14, 2019

The arrival of predictive biomarkers for monitoring therapy response to natural compounds in cancer drug discovery.

The arrival of predictive biomarkers for monitoring therapy response to natural compounds in cancer drug discovery.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 03, 2018

Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers.

Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers.

Journal: Cancer medicine

Published: December 21, 2017

Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO).

Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO).

Journal: BMC cancer

Published: October 24, 2017

The Human Cancer Pathology Atlas: An open-access source for more than 900,000 Kaplan-Meier plots and 5 million cancer tissue images.

The Human Cancer Pathology Atlas: An open-access source for more than 900,000 Kaplan-Meier plots and 5 million cancer tissue images.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 30, 2017

Prediction of therapy response in ovarian cancer: Where are we now?

Prediction of therapy response in ovarian cancer: Where are we now?

Journal: Critical reviews in clinical laboratory sciences

Published: April 27, 2017

Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.

Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: December 05, 2016

Outcome of Breast Cancer in Moroccan Young Women Correlated to Clinic-Pathological Features, Risk Factors and Treatment: A Comparative Study of 716 Cases in a Single Institution.

Outcome of Breast Cancer in Moroccan Young Women Correlated to Clinic-Pathological Features, Risk Factors and Treatment: A Comparative Study of 716 Cases in a Single Institution.

Journal: PloS one

Published: July 26, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026